Amgen Inc. (AMGN)
NASDAQ
Closed
Sep 4, 2026
Day's Range
435.0052 wk Range
269.77Profile - AMGN - Amgen Inc.
Profile
Mic Code
XNGS
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
31.50K
Amgen Inc. is a global biotechnology company that develops, manufactures, and commercializes human therapeutics for serious diseases. Its portfolio centers on biologic medicines and specialty therapies used in oncology, inflammation, cardiovascular disease, bone health, nephrology, and rare diseases. The company also markets biosimilars that provide alternatives to established biologic drugs, expanding its presence across major pharmaceutical categories. Amgen serves healthcare providers, hospitals, clinics, pharmacies, and wholesalers in markets around the world, with products distributed through both institutional and commercial channels. Its current business is built around discovering and delivering treatments that address high unmet medical needs, making Amgen a significant player in the biopharmaceutical sector and a key provider of advanced medicines within modern healthcare markets.
Profile Details
Type
Common Stock
Address
One Amgen Center Drive
City
Thousand Oaks
State
CA
Zip
91320-1799
Country
United States
Phone
805 447 1000
Key Executives - AMGN - Amgen Inc.
Key executives
Cross Listings - AMGN - Amgen Inc.
Also listed on
The same company trading on other exchanges.
- AMGNCLBVS
- AMGXETR, FSX, XHAN, XDUS, Munich
- 0R0TLSE
- AMGdCBOE
- 1AMGNMTA
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
